The InnoMuNiCH Cooperation Platform

InnoMuNiCH –Innovations through Munich-Nippon Cooperation in Healthcare

New! Current Cooperation Opportunities (between Japan and Bavaria)

Aim of the Cooperation Platform

  • Accelerating innovation in the field of biomedicine by initiating and accelerating bi-national cooperations between Germany and Japan.
  • Connecting relevant specialists through a broad and strong network provided by each Committee member.
  • Once a cooperation opportunity is submitted to the Platform, Committee members can evaluate, further distribute and share this project idea with relevant specialists from their networks in order to identify R&D collaborators or business partners.
  • Time and effort to establish contact to the right partner can thus be remarkably shortened, and cooperation between both countries will be promoted – strengthening the leading position of Japan and Germany in the global healthcare value chain.
  • As a result of this bi-national cooperation, IP will be created to the benefit of both countries, country-market specific innovations will be accelerated, and Platform Committee members will have first access to breakthrough technologies.
  • The Platform consists of an e-mail group of carefully selected Committee members, who can join the Platform on invitation only. Platform Committee members activities are volunteer-based and membership is free of charge.
  • The Platform consists of an Honorary President (Prof. Winnacker), a Chairman Germany (Prof. Horst Domdey, BioM), a Chairman Japan (Dr. Kouichi Akahane), and a core group of specialists, representing a larger network of relevant players and decision makers in the biopharmaceutical health sector.
  • The Platform was launched in June 2018 and is now effective for a trial phase until the end of December 2018, then extended for another two years based on a careful assessment by the Committee members.

If you wish to submit a cooperation project to the Committee, please fill out the project application form and send it to Misuzu Matsuyama, (Japanese, English) or Dr. Stephanie Wehnelt, (German, English). The project can be submitted by a German or a Japanese partner from industry or research, looking for a cooperation partner in the other country.


Platform Committee Members


  • Prof. Dr. Ernst-Ludwig Winnacker, former Secretary General of the Human Frontier Science Program (HFSP) and Secretary General of the European Research Council (ERC),
    Honorary President of the InnoMuNiCH Cooperation Platform


  • Prof. Dr. Horst Domdey, CEO, BioM Biotech Cluster Development,
    Chairman Germany of the InnoMuNiCH Cooperation Platform
  • Prof. Dr. Uwe Bücheler, Senior Vice President Biopharmaceuticals Operations, Boehringer Ingelheim Biopharmaceuticals GmbH
  • Dr. Markus Enzelberger, Senior Vice President, Morphosys
  • Dr. Jörn-Peter Halle, Vice President, Merck
  • Dr. Berthold Hinzen, VP and Head Business Development & Licensing General Medicine, Bayer
  • Dieter Lingelbach, COO, Sirion Biotech
  • Dr. Frank Mathias, CEO, Rentschler Biopharma
  • Prof. Dr. Rolf Schmid, Director, Bio4Business
  • Dr. Garwin Pichler, CEO, Preomics
  • Prof. Dr. Heike Andrea Wieland, External Affairs, Sanofi-Aventis Deutschland


  • Dr. Koichi Akahane, Executive Officer and Vice President of Oncology Function, Daiichi-Sankyo
    Chairman Japan of the InnoMuNiCH Cooperation Platform
  • Prof. Dr. Takashi Asada, Lab. of Embryonic Stem Cell Research, Department of Regeneration Science and Engineering, Kyoto University
  • Prof. Dr. Kazunori Kataoka, Director General, Innovation Center of Nanomedicine
  • Dr. Christian Geltinger, Representative, The Bavarian Representative in Japan
  • Prof. Dr. Hiromichi Kimura, Visiting Professor, Pharmaco-Business Innovation, Graduate School of Pharmaceutical Sciences, The University of Tokyo
  • Prof. Hiroshi Nagano, Visiting Fellow, Center for Research and Development Strategy, Japan Science and Technology Agency (JST), AAAS Fellow
  • Ryuta Nomura, CEO, Chairman of the Board, Central Institute of Experimental Medicine

back to InnoMuNiCH

Dr. Stephanie Wehnelt
Dr. Stephanie Wehnelt

Head of International Affairs